Back to results
US 10,329,324 B2Granted
Indoline compounds as granzyme B inhibitors
AssigneeviDA Therapeutics Inc.
InventorDale R. Cameron
Life of this patent
Estimating the term…
Abstract
Granzyme B inhibitor compounds, compositions that include the compounds, and methods for using the compounds. The compounds of the invention have advantageous water solubility and effectively inhibit Granzyme B.
Claims9
A compound having Formula (III):
- or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, wherein:
- R1a is tetrazole or triazole;
- R3 is H or C1-C4 alkyl substituted with a carboxylic acid or carboxylate group;
- R4 is C3-C6 cycloalkyl or C1-C6 alkyl optionally substituted with hydroxyl or C1-C6 alkoxy;
- and
- R10 is —(CH2)n—CO2H, wherein n is 2, 3, 4, 5, or 6,
- optionally wherein one or more single methylene carbons are substituted with a fluoro, hydroxy, amino, C1-C3 alkyl, or C6-C10 aryl group,
- optionally wherein one or more single methylene carbons are substituted with two fluoro or C1-C3 alkyl groups,
- optionally wherein one or more single methylene carbons are substituted with two alkyl groups that taken together with the carbon to which they are attached form a 3, 4, 5, or 6-membered carbocyclic ring, or
- optionally wherein adjacent carbon atoms from an unsaturated carbon-carbon bond or taken together form a benzene ring;
- or
- R10 is
- wherein n is 1, 2, 3, or 4, and
- optionally, for n=3 or 4, wherein adjacent carbon atoms from an unsaturated carbon-carbon bond.
11 more elements
Dependencies are inferred from the claim text.